The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Neurological aspects of drug misuse
Abstract
The misuse of illicit drugs and prescription medications may cause neurological complications from overdose, withdrawal and long-term chronic misuse. Drug-use disorder has become particularly important and complex because of different patterns of presentation associated with new psychoactive substances and the growing misuse of opioids, synthetic cannabinoids and stimulants. We review worldwide demographic data of drug-use disorder and discuss the individual classes of agents, newer developments relating to understanding the mechanisms of action and the patterns of administration, usage, toxicity and withdrawal. We consider the difficulties in assessment and the specific acute syndromes of toxicity that present with neurological manifestations. We review the neurological patterns of longer-term complications and consider the effects of drug misuse-related trauma, infection, seizures, stroke, toxic leucoencephalopathy, cognitive impairment, movement disorders and neuromuscular complications. The neurological consequences of drug-use disorder disproportionately affect the young and can have devastating effects on innocent lives. It is essential that neurologists recognise acute toxicity early and understand the longer-term consequences of drug-use disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Langston, J. W. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-179006 · Cited by 424
Stroke and methamphetamine use in young adults: a review
Lappin, J. M., Darke, S., & Farrell, M. (2017) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316071 · Cited by 191
Johnson, J., Pizzicato, L., Johnson, C., & Viner, K. (2021) · Injury Prevention · doi:10.1136/injuryprev-2020-043968 · Cited by 183
Oussalah, A., Julien, M., Levy, J., Hajjar, O., Franczak, C., Stephan, C., Laugel, E., Wandzel, M., Filhine-Trésarrieu, P., Green, R., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040551 · Cited by 169
A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse
Tsatsakis, A. M., Docea, A. O., Călina, D. C., Tsarouhas, K., Zamfira, L.-M., Mitruţ, R., Sharifi‐Rad, J., Kovatsi, L., Siokas, V., Dardiotis, E., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091295 · Cited by 155
Designer drugs 2015: assessment and management
Weaver, M. F., Hopper, J. A., & Gunderson, E. W. (2015) · Addiction Science & Clinical Practice · doi:10.1186/s13722-015-0024-7 · Cited by 140
Adverse Health Effects of Marijuana Use
Volkow, N. D., Compton, W. M., & Weiss, S. R. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1407928 · Cited by 110
Cannabis-Related Disorders and Toxic Effects
Gorelick, D. A. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2212152 · Cited by 92
Fatal toxic leukoencephalopathy: clinical, radiological, and necropsy findings in two patients
Ryan, A. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.047134 · Cited by 89
Cocaine Use and Risk of Ischemic Stroke in Young Adults
Cheng, Y.-C., Ryan, K., Qadwai, S., Shah, J., Sparks, M., Wozniak, M., Stern, B., Phipps, M., Cronin, C., Magder, L., et al. (2016) · Stroke · doi:10.1161/strokeaha.115.011417 · Cited by 82
Research works printed but not linked: 3
- Watson RR , Zibadi S . Addictive substances and neurological disease. Academic Press, 2017.
- World Drug review . Recent developments involving psychedelics. 2023. Available: https://www.unodc.org/res/WDR-2023/WDR23_B3_CH2_psychedelics.pdf
- Orhurhu VJ , Vashisht R , Claus LE . Ketamine toxicity. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2025. Available: https://www.ncbi.nlm.nih.gov/books/NBK541087/
Cited by
Flubromazepam intoxication causing prolonged coma and multifocal cerebral ischaemia
Pitlo, L., Ruigrok, Y. M., Migchelsen, F. E. L., et al. (2026) · Practical Neurology · doi:10.1136/pn-2025-005012 · Cited by 1
Feistkorn, E., Böhning, D. A., Reuser, M., Davis, E., Begemann, K., & Greiner, M. (2026) · Clinical Toxicology · doi:10.1080/15563650.2026.2647647
Brigo, F., & Lattanzi, S. (2026) · Practical Neurology · doi:10.1136/pn-2025-004912
Role of incretins in Alzheimer’s disease and their impact on behavioral aspects
Yang, J., Mao, T., & Gao, L. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004195
Correa, L., Miño-Bernal, J., Romero-Correa, M. P., et al. (2026) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2026.100658
Metadata
- Authors
- Howard, R. S., Holmes, P., & Dargan, P.
- Affiliations
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Venue
- Practical Neurology
- Publisher
- BMJ
- Published
- 2025-05-27
- Volume
- 25
- Issue
- 5
- Pages
- 411-421
- ISSN
- 1474-7758 (ISSN-L)
- 1474-7766
- OpenAlex
- W4410778754
- Semantic Scholar
- f5a3be3fff4c043118c6cd58a78768b4d6b99187
- Cited by
- 5
- References
- 33
- Citations by year
- 2026: 5
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Practical Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- drug abuse, drug use disorders, neurological complications, new psychoactive substances, opioid misuse, synthetic cannabinoids, stimulants, drug overdose, drug withdrawal, cognitive impairment, movement disorders, seizures, stroke, infection, neuromuscular complications
- MeSH terms
- Drug Misuse, Humans, Nervous System Diseases, Illicit Drugs, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurological aspects of drug misuse. https://app.cochat.ai/papers/10.1136/pn-2023-003796
- The paper
- Howard, R. S., Holmes, P., & Dargan, P. (2025). Neurological aspects of drug misuse. Practical Neurology. https://doi.org/10.1136/pn-2023-003796
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.